Recent advances in cancer treatment continue to provide optimism for patients. Scientists are diligently exploring novel approaches, including immunotherapy , targeted agents, and personalized approaches. A significant study published this week highlights the effectiveness of a emerging drug in managing advanced NSCLC. Furthermore, current investig